Medios AGMEDOF 88 PS Ratio is 0.50 as of Jun. 28, 2026, which is 85% above its 10-year median of 0.27. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $71.50. The stock has 2 warning signs investors should review. Among 116 Medical Distribution companies, Medios AG ranks better than 83.62% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Medios AG's share price is $50.00.
Medios AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $99.64. Hence, Medios AG's PS Ratio for today is 0.50.
Good Sign:
Medios AG stock PS Ratio (=0.14) is close to 10-year low of 0.14.
The historical rank and industry rank for Medios AG's PS Ratio or its related term are showing as below:
MEDOF'
s PS Ratio Range Over the Past 10 Years
Min: 0.14 Med: 0.27 Max: 2.78
Current: 0.14
During the past 13 years, Medios AG's highest PS Ratio was 2.78. The lowest was 0.14. And the median was 0.27.
MEDOF's PS Ratio is ranked better than 83.62% of 116
companies
in the Medical Distribution industry
Industry Median: 0.41
vs MEDOF: 0.14
During the past 12 months, the average Revenue per Share Growth Rate of Medios AG was 13.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.80% per year.
During the past 13 years, Medios AG's highest 3-Year average Revenue per Share Growth Rate was 1201.90% per year. The lowest was -85.60% per year. And the median was 15.65% per year.
Back to Basics: PS Ratio
Medios AG (OTCPK:MEDOF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Medios AG PS Ratio Related Terms
Medios AG PS Ratio Historical Data
* Premium members only.
The historical data trend for Medios AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medios AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Medios AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Medios AG's Share Price of today is $50.00. Medios AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $99.64.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Medios AG (MEDOF) has a PS Ratio of 0.50 as of Jun. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Medios AG and its competitors. This is 85% above median its historical median of 0.27. Over the past decade, Medios AG's PS Ratio has ranged from 0.14 to 2.78. According to the industry distribution chart, Medios AG ranks #19 out of 116 companies in the Medical Distribution industry, placing it in the top 16.4%.
Is Medios AG's PS Ratio too high?
Medios AG's current PS Ratio of 0.50 is 85% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 2.78. The Medical Distribution industry median PS Ratio is 0.41. Medios AG's value of 0.50 is 22% above this industry median. Based on the distribution chart, Medios AG ranks #19 out of 116 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medios AG ranks #19 out of 116 companies for PS Ratio. This places Medios AG in the top 16% of its industry — outperforming the majority of peers. The industry median PS Ratio is 0.41. Medios AG's value of 0.50 is 22% above this benchmark. Historically, Medios AG's own PS Ratio has ranged from 0.14 to 2.78 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 0.41, Medios AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.41, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current PS Ratio of 0.50 is 22% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current PS Ratio is 0.50, which is 85% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current PS Ratio of 0.50. The stock's GF Value™ is $71.50, compared to a current price of $50.00 — trading 30.1% below its estimated fair value. The current PS Ratio is 0.50, which is 85% above median its 10-year median of 0.27 and 22% above the Medical Distribution industry median of 0.41. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Medios AG (MEDOF), the current PS Ratio is 0.50 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 30.1% below its estimated GF Value™ of $71.50.
Key valuation signals for MEDOF:
PS Ratio: 0.50 (85% above median its 10-year median of 0.27)
GF Value™: $71.50 vs. price of $50.00 (30.1% below fair value)
Industry Position: 22% above the Medical Distribution median (#19 of 116)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 
